Barclays Forecasts Strong Price Appreciation for Tandem Diabetes Care (NASDAQ:TNDM) Stock
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price objective boosted by equities researchers at Barclays from $58.00 to $60.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical device company’s stock. Barclays‘s target price would suggest a potential upside of 92.86% […]
More Stories
Fair Isaac (NYSE:FICO) Given New $2,000.00 Price Target at Robert W. Baird
Fair Isaac (NYSE:FICO – Free Report) had its price objective upped by Robert W. Baird from $1,700.00 to $2,000.00 in...
Pinnacle West Capital (NYSE:PNW) Releases FY 2025 Earnings Guidance
Pinnacle West Capital (NYSE:PNW – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings...
ARK Next Generation Internation ETF (NYSEARCA:ARKW) Sets New 1-Year High – What’s Next?
Shares of ARK Next Generation Internation ETF (NYSEARCA:ARKW – Get Free Report) reached a new 52-week high on Wednesday ....
WisdomTree U.S. LargeCap Dividend Fund (NYSEARCA:DLN) Sets New 12-Month High – Here’s What Happened
Shares of WisdomTree U.S. LargeCap Dividend Fund (NYSEARCA:DLN – Get Free Report) reached a new 52-week high during trading on...
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (NYSEARCA:BBMC) Reaches New 12-Month High – What’s Next?
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (NYSEARCA:BBMC – Get Free Report)’s stock price hit a new 52-week high during...
iShares MSCI KLD 400 Social ETF (NYSEARCA:DSI) Reaches New 12-Month High – Here’s Why
iShares MSCI KLD 400 Social ETF (NYSEARCA:DSI – Get Free Report)’s share price hit a new 52-week high during mid-day...